Pain in chronic kidney disease: Prevalence, cause and management

Journal of Renal Care

Volumn 37, Issue 2, 2011, Pages 114-122

  Kafkia, Theodora ^a   Chamney, Melissa ^b   Drinkwater, Anna ^c   Pegoraro, Marisa ^d   Sedgewick, John ^e  

^a 2nd IKA ETAM Hospital   (Greece)

^b CITY UNIVERSITY   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e TEESSIDE UNIVERSITY   (United Kingdom)

Author keywords

Chronic kidney disease; Medication; Non pharmacological approaches; Pain

Indexed keywords

ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; MALE; METHODOLOGY; NURSE ATTITUDE; PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; PATIENT ATTITUDE; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; FEMALE; HUMANS; MALE; NURSE'S ROLE; PAIN; PAIN MEASUREMENT; PALLIATIVE CARE; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITY OF LIFE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 79955766527     PISSN: 17556678     EISSN: 17556686     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2011.00234.x     Document Type: Article

References (66)

1. Abbot N.C. & Harkness E.F. (2001). Spiritual healing as a therapy for chronic pain: a randomized clinical trial. Pain 91, 79-89.
2. Anderson K.O., Mendoza T.R., Valero V. et al. (2000). Minority cancer patients and their providers: pain management attitudes and practice. Cancer 88, 1929-1938.
3. Angst M., Buhrer M. & Lotsch J. (2000). Insidious intoxication after morphine treatment in renal failure: delayed onset of morphine-6-glucuronide action. Anesthesiology 97, 1473-1476.
4. Bailie G., Mason N., Bragg-Gresham J. et al. (2004). Analgesic prescription patterns among hemodialysis patients in DOPPS: potential for underpre-scription. Kidney International 65, 2419-2425.
5. Bajwa Z.H., Gupta S., Warfield C.A. et al. (2001). Pain management in polycystic kidney disease. Kidney International 60, 1631-1644.
6. Barakzoy A. & Moss A. (2006). Efficacy of the World Health Organisation analgesic ladder to treat pain in End-Stage Renal Disease. Journal of American Society of Nephrology 17, 3198-3203.
7. Barnason S., Merboth M., Pozehl B. et al. (1998). Utilising an outcomes approach to improve pain management by nurses: a pilot study. Clinical Nurse Specialist 12, 28-36.
8. Bower S. (1982). Plasma protein binding of fentanyl: the effect of hyperlipoproteinae-mia and chronic renal failure. Journal of Pharmacy & Pharmacology 34, 102-106.
9. Brenner B. M. (2008). The Kidney. 8th edn. Philadelphia WB Saunders.
10. Brown S., Bowman J. & Eason F. (1999). Assessment of nurses' attitudes and knowledge regarding pain management. Journal of Continuing Education in Nursing 30, 132-139.
11. Carson M.G. & Mitchell G.J. (1998). The experience of living with persistent pain. Journal of Advanced Nursing 6, 1242-1248.
12. Chambers E.J., Germain M., Brown E. (eds). (2004). Supportive Care for the Renal Patient. London Oxford University Press.
13. Chang V.T., Hwang S.S., Feurman M. et al. (2000). The Memorial symptom assess-ment scale short form (MSAS-SF). Cancer 89, 1162-1171.
14. Clarke E., French B., Bilodeau M. et al. (1996). Pain and management knowledge, attitudes, and clinical practice: the impact of nurses' characteristics and education. Journal of Pain and Symptom Management 11, 18-31.
15. Cleeland C., Gonin R., Hatfield A.K. et al. (1994). Pain and its treatment in outpatients with metastatic cancer. NEJM 330, 592-596.
16. Cohen L.M., Germain M.J., Poppel D.M. et al. (2000). Dialysis discontinuation and withdrawl of dialysis. American Journal of Kidney Diseases 36, 140-144.
17. Cohen L., Moss A., Weisbord S. et al. (2006). Renal palliative care. Journal of Palliative Medicine 4, 977-992.
18. Cohen S., Patel S., Khetpal P. et al. (2007). Pain, sleep disturbance, and quality of life in patients with chronic kidney disease. Clin J Am Soc Nephrol 2, 919-925.
19. Coral I.M., Moore A.R. & Strunin L. (1980). Plasma concentration of fentanyl in normal surgical patients and those with severe renal and hepatic disease. British Journal of Anaesthesia 52, 101.
20. Davison S.N. (2003). Pain in hemodialysis patients: prevalence, cause, severity, and management. American Journal of Kidney Disease 6, 1239-1247.
21. Davison S.N. & Jhangri G.S. (2005). The impact of chronic pain on depression, sleep, and the desire to withdrawal from dialysis in hemodialysis patients. Journal of Pain and Symptom Management 30, 465-473, p. 327.
22. Davison S.N. (2005). Chronic pain in end-stage renal disease. Advances in Chronic Kidney Disease 42, 326-334.
23. Davison S.N. (2007). The prevalence and management of chronic pain in end-stage renal disease. Journal of Palliative Medicine 6, 1277-1287.
24. Davison S. & Jhangri G. (2010). Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. Journal of Pain Symptom Management, 39(3), 477-485.
25. Dean M. (2004). Opioids in renal failure and dialysis patients. Journal of Pain Symptom Management 28, 497-504.
26. Department of Health. (2005). National Service Framework for Renal Services. Part Two: Chronic Kidney disease, acute renal failure and end of life care.
27. Desmeules J.A. (2000, Suppl A). The tramadol option. Europeon Journal of Pain 4, S15-S21.
28. Douglas C., Murtagh F., Chambers E. et al. (2009). Symptom management for the adult patient dying with advanced chronic kidney disease: a review of the literature and development of evidence-based guidelines by a United Kingdom Expert Consensus Group. Palliative Medicine 23, 103-110.
29. Faisinger R., Davison S.N. & Brennies C. (2003). A supportive care model for dialysispatients. Palliative Medicine 17, 81-82.
30. Fortina F., Agllata S., Ragazzoni et al. (1999). Chronic Pain during dialysis: pharma-cologic therapy and its costs. Minerva urologica e nefrologica 51, 85-87.
31. Furlan V., Hafi A., Dessalles M.C. et al. (1999). Methadone is poorly removed by hae-modialysis. Nephrology, Dialysis, Transplantation 14, 254-255.
32. Good M., Staton-Hicks M., Grass J.A. et al. (2001). Relaxation and music to reduce postsurgical pain. Journal of Advanced Nursing 33(2), 208-215.
33. Guay D.R., Awni W.M., Findlay J.W. et al. (1988). Pharmacokinetics and pharmacody-namics of codeine in end-stage renal disease. Clinical Pharmacology and Therapeutics 43, 63-71.
34. Heiwe S. & Bjuke M. (2009). An Evil Heritage: interview study of pain and Autosomal Dominant Polycystic Kidney Disease. Pain Management Nursing 3, 134-141.
35. Higgins R. (2010). NKF Controlled Document No. 37, Pain in Kidney or Urine Diseases. Available from: (accessed 29 November 2010).
36. Ingham J.M. & Portenoy R.K. (2004). The measurement of pain and other symptoms. In Oxford Textbook of Palliative Medicine (eds Doyle D., Hanks G., Cherny N., & Calman K.), 3rd edn, pp. 167-184. Oxford Oxford University Press.
37. Merskey H. & Bogduk N. (1994). Classification of Chronic Pain. Seattle, WA International Association for the Study of Pain Press p. 210.
38. Kurella M., Bennett W. & Chertow G. (2003). Analgesia in patients with ESRD: a review of available evidence. American Journal of Kidney Disease 2, 217-228.
39. Lang E., Benotsch E., Fick L. et al. (2000). Adjunctive non-pharmacological analgesia for invasive medical procedures: a randomised trial. The Lancet, 355 (9214), 1486-1490.
40. Lichodziejewska-Niemierko M. & Rutkowski B. (2008). Palliative care in nephrology. Journal of Nephrology 21(Suppl 13), S153-S157.
41. Max M. (1990). Improving outcomes of analgesic treatment: is education enough Annals of Internal Medicine 113(11), 885-889.
42. McCaffery M.S. & Ferrell B.R. (1991). How would you respond to these patients in pain. Nursing 91, 34-37.
43. McCaffery M. (2001). Overcoming barriers to pain management Nursing 31(4), 18.
44. McQuay H. & Moore A. (1988). An Evidence Based Resource for Pain Relief. Oxford Oxford University Press.
45. Mercadante S., Caligara M., Sapio M. et al. (1997). Subcutaneous fentanyl infusion in a patient with bowel obstruction and renal failure. Journal of Pain and Symptom Management 13, 241-244.
46. Merskey H. & Bogduk N. (1994). Classification of Chronic Pain. Seattle, WA International Association for the Study of Pain Press, p. 210.
47. Moss A.H. (2000). A new clinical practice guideline on initiation and withdrawal of dialysis that makes explicit the role of palliative medicine. Journal of Palliative Medicine 3, 253-260.
48. Murtagh F., Addington-Hall J. & Higginosn I.J. (2007). The prevalence of symptoms in end-stage renal disease: a systematic review. Advances in Chronic Kidney Disease 14, 82-99.
49. Murtagh F.E., Addington-Hall J.M., Edmonds P.M. et al. (2007). Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in Stage 5 chronic kidney disease managed without dialysis. Journal of Palliative Medicine 10(6), 1266-1276.
50. Nayak-Rao (2011). Achieving effective pain relief in patients with chronic kidney disease: a review of analgesics in renal failure. Journal of Nephrology 24, 35-40 published online 01/04/2010.
51. Noble H., Meyer J., Bridges J. et al. (2010). Exploring symptoms in patients managed without dialysis: a Qualitative research study. Journal of Renal Care 36(1), 9-15.
52. Portenoy R., Kornblith A., Wong G., et al. (1994). Pain in ovarian cancer patients. Cancer 74, 907-915.
53. Rehm M. (2003). Pain in end stage renal disease. Nephrology Nursing Journal 3, 340-341.
54. Rizk D., Jurkovitz C., Veledar E. et al. (2009). Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis. Clinical Journal American Society Nephrology 4, 560-566.
55. Salisbury E., Game D., Al-Shakarchi I. et al. (2009). Changing practice to improve pain control for renal patients. Postgraduate Medical Journal 85, 30-33.
56. Sedgewick J., Noble H. & Ho T.M. (2010). Integration of palliative care for patients with stage 5 Chronic Kidney Disease. Journal of Renal Care 36(4), 218-226.
57. Shatin L. (1970). Alteration of mood via music: a study of the vectoring effect. Journal of Psychology 75(2), 81-86.
58. Sherwood G., Adams-McNeill J., Starck P.L. et al. (2000). Qualitative assessment of hospitalized patients' satisfaction with pain management. Research in Nursing and Health 6, 486-495.
59. Tafas C.A., Patiraki E., McDonald D.D. et al. (2002). Testing an instrument measuring Greek Nurses' knowledge and attitudes regarding pain. Cancer Nursing 25 (1), 8-14.
60. The Lothian Palliative Care Guidelines. (2009). Available from: (accessed 19 February 2011).
61. Vines S. (1988). The therapeutics of guided imagery. Holistic Nursing Practice 2(3), 34-44.
62. Weisbord S.D., Fried L.E., Arnold R.M. et al. (2005). Prevalence, severity, and impor-tance of physical and emotional symptoms in chronic hemodialysis patients. Journal of the American Society of Nephrology 8, 2487-2494.
63. Weisbord S.D., Fried L.F., Arnold R.M. et al. (2004). Development of a symptom assessment instrument for Chronic Hemodialysis Patients: the Dialysis Symptom Index. Journal of Pain and Symptom Management 3, 226-240.
64. Whelton A., Stout R.L., Spilman P.S. et al. (1990). Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure: a prospective, randomized, crossover comparison. Annals of Internal Medicine 112, 568-576.
65. Yurtkurana M., Alpa A., Yurtkuranb M. et al. (2007). A modified yoga-based exercise program in hemodialysis patients: a randomized controlled study. Complementary Therapies in Medicine 15(3), 164-171.
66. Zech D.F.J., Ground S., Lynch J. et al. (1995). Validation for World Health Organisation Guidelines for cancer relief: a 10 year prospective study. Pain 63, 65-76.